{
    "id": "5e338cf5fbd6abf43b00005d",
    "question": "Are Chernobyl survivors at increased risk for breast cancer?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the available documents to see if there is any evidence of an increased risk of breast cancer in Chernobyl survivors. According to Document [1] (Title: Surgery_Schwartz), radiation exposure during adolescence, a period of active breast development, magnifies the deleterious effect of radiation on the breast. Document [6] (Title: Surgery_Schwartz) also states that radiation therapy to the chest increases the risk of breast cancer if exposure occurs while the breast is still developing. Document [10] (Title: InternalMed_Harrison) mentions that women treated with mantle radiation therapy for Hodgkin\u2019s lymphoma have a 30% risk of developing breast cancer by age 55 years. Document [14] (Title: Gynecology_Novak) lists radiation exposure as a risk factor for breast cancer. Given these points, it is reasonable to conclude that Chernobyl survivors, who were exposed to radiation, including possibly during adolescence, may be at increased risk for breast cancer. However, the actual risk is not explicitly stated in the provided documents. We need to look for any information that could provide a definitive answer.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "Surgery_Schwartz_3770",
            "title": "Surgery_Schwartz",
            "content": "In both circumstances, radiation exposure during adolescence, a period of active breast development, magnifies the deleterious effect. Studies also sug-gest that the risk of breast cancer increases as the amount of alcohol a woman consumes increases.49 Alcohol consumption is known to increase serum levels of estradiol. Finally, evidence suggests that long-term consumption of foods with a high fat content contributes to an increased risk of breast cancer by increasing serum estrogen levels.Risk Assessment ModelsThe average lifetime risk of breast cancer for newborn U.S. women is 12%.50,51 The longer a woman lives without cancer, the lower her risk of developing breast cancer. Thus, a woman age 50 years has an 11% lifetime risk of developing breast cancer, and a woman age 70 years has a 7% lifetime risk of developing breast cancer. Because risk factors for breast cancer interact, evaluating the risk conferred by combinations of risk factors is difficult. There are several risk"
        },
        {
            "id": "Surgery_Schwartz_3769",
            "title": "Surgery_Schwartz",
            "content": "pregnancy is also protective, so older age at first live birth is associated with an increased risk of breast cancer. Finally, there is an association between obesity and increased breast cancer risk. Because the major source of estrogen in postmenopausal women is the conversion of andro-stenedione to estrone by adipose tissue, obesity is associated with a long-term increase in estrogen exposure.Nonhormonal risk factors include radiation exposure. Young women who receive mantle radiation therapy for Hodg-kin\u2019s lymphoma have a breast cancer risk that is 75 times greater than that of age-matched control subjects. Survivors of the atomic bomb blasts in Japan during World War II have a very high incidence of breast cancer, likely because of somatic muta-tions induced by the radiation exposure. In both circumstances, radiation exposure during adolescence, a period of active breast development, magnifies the deleterious effect. Studies also sug-gest that the risk of breast cancer increases"
        },
        {
            "id": "InternalMed_Harrison_8553",
            "title": "InternalMed_Harrison",
            "content": "There are no familial associations in CML. The risk of developing CML is not increased in monozygotic twins or in relatives of patients. No etiologic agents are incriminated, and no associations exist with exposures to benzene or other toxins, fertilizers, insecticides, or viruses. CML is not a frequent secondary leukemia following therapy of other cancers with alkylating agents and/or radiation. Exposure to ionizing radiation (e.g., nuclear accidents, radiation treatment for ankylosing spondylitis or cervical cancer) has increased the risk of CML, which peaks at 5\u201310 years after exposure and is dose-related. The median time to development of CML among atomic bomb survivors was 6.3 years. Following the Chernobyl accident, the incidence of CML did not increase, suggesting that only large doses of radiation can cause CML. Because of adequate protection, the risk of CML is not increased in individuals working in the nuclear industry or among radiologists in recent times."
        },
        {
            "id": "Pathology_Robbins_1970",
            "title": "Pathology_Robbins",
            "content": "\u2022 Environmental exposure and cancer development. Any cell capable of division that has sustained mutations has the potential to become cancerous. Thus, an increased incidence of neoplasms may occur in any organ after exposure to ionizing radiation. The level of radiation required to increase the risk of cancer development is difficult to determine, but there is little doubt that acute or prolonged exposures that result in doses of 100 mSv cause serious consequences, including cancer. This is documented by the increased incidence of leukemias and tumors at various sites (such as thyroid, breast, and lung) in survivors of the atomic bombings of Hiroshima and Nagasaki, the increase in thyroid cancers in survivors of the Chernobyl accident, and the development of \u201csecond cancers,\u201d such as acute myeloid leukemia, myelodysplastic syndrome, and solid tumors, in individuals who received radiation therapy for cancers such as Hodgkin lymphoma. It is believed that the risk of secondary cancers"
        },
        {
            "id": "Pathology_Robbins_1393",
            "title": "Pathology_Robbins",
            "content": "Radiation, whatever its source (UV rays of sunlight, radiographs, nuclear fission, radionuclides), is an established carcinogen. Unprotected miners of radioactive elements have a 10-fold increased incidence of lung cancers. A follow-up study of survivors of the atomic bombs dropped on Hiroshima and Nagasaki disclosed a markedly increased incidence of leukemia after an average latent period of about 7 years, as well as increased mortality rates for thyroid, breast, colon, and lung carcinomas. The nuclear power accident at Chernobyl in the former Soviet Union continues to exact its toll in the form of high cancer incidence in the surrounding areas. More recently, it is feared that radiation release from a nuclear power plant in Japan damaged by a massive earthquake and tsunami will result in significantly increased cancer incidence in the surrounding geographic areas."
        },
        {
            "id": "Pathology_Robbins_4406",
            "title": "Pathology_Robbins",
            "content": "Ionizing Radiation. Radiation to the chest increases the risk of breast cancer if exposure occurs while the breast is still developing. For example, breast cancer develops in 25% to 30% of women who underwent irradiation for Hodgkin lymphoma in their teens and 20s, but the risk for women treated later in life is not elevated. Other Risk Factors. Postmenopausal obesity, postmenopausal hormone replacement, mammographic density, and alcohol consumption also have been implicated as risk factors. The risk associated with obesity probably is due to exposure of the breast to estrogen produced by adipose tissue. In keeping with this, obesity is only associated with an increased risk of tumors that express ER. The three major subtypes of breast cancer defined by differential expression of hormone receptors and HER2 arise through more-or-less distinct pathways that involve the stepwise acquisition of driver mutations in the epithelial cells of the duct/lobular system ("
        },
        {
            "id": "Surgery_Schwartz_10825",
            "title": "Surgery_Schwartz",
            "content": "Radiation (approximately 4000 cGy) is also an integral part of the manage-ment of patients with Hodgkin\u2019s disease. It is now known that a history of exposure to low-dose ionizing radiation to the thyroid gland places the patient at increased risk for developing thyroid cancer. The risk increases linearly from 6.5 to 2000 cGy, beyond which the incidence declines as the radiation causes destruc-tion of the thyroid tissue. The risk is maximum 20 to 30 years after exposure, but these patients require lifelong monitoring. During the nuclear fallout from Chernobyl in 1986, 131I release was accompanied by a marked increase in the incidence of both benign and malignant thyroid lesions noted within 4 years of exposure, particularly in children.17 Most thyroid carcinomas following radiation exposure are papillary, and some of these cancers with a solid type of histology and presence of RET/PTC translocations appear to be more aggressive. In general, there is a 40% chance that patients"
        },
        {
            "id": "Pathology_Robbins_4553",
            "title": "Pathology_Robbins",
            "content": "Environmental Factors. The major risk factor predisposing to thyroid cancer is exposure to ionizing radiation, particularly during the first 2 decades of life. In keeping with this finding, there was a marked increase in the incidence of papillary carcinomas among children exposed to ionizing radiation after the Chernobyl nuclear disaster in 1986. Deficiency of dietary iodine (and by extension, an association with goiter) is linked with a higher frequency of follicular carcinomas. As mentioned earlier, papillary carcinomas are the most common form of thyroid cancer. These tumors may occur at any age, and they account for the vast majority of thyroid carcinomas associated with previous exposure to ionizing radiation. Papillary carcinomas are solitary or multifocal lesions. Some tumors may be well circumscribed and encapsulated; others infiltrate the adjacent parenchyma and have ill-defined margins. The cut surface sometimes reveals papillary foci that point to the diagnosis ("
        },
        {
            "id": "InternalMed_Harrison_6844",
            "title": "InternalMed_Harrison",
            "content": "In addition to the other factors, radiation is a risk factor in younger women. Women who have been exposed before age 30 years to radiation in the form of multiple fluoroscopies (200\u2013300 cGy) or treatment for Hodgkin\u2019s disease (>3600 cGy) have a substantial increase in risk of breast cancer, whereas radiation exposure after age 30 years appears to have a minimal carcinogenic effect on the breast."
        },
        {
            "id": "InternalMed_Harrison_6676",
            "title": "InternalMed_Harrison",
            "content": "The risk of lung cancer appears to be higher among individuals with low fruit and vegetable intake during adulthood. This observation led to hypotheses that specific nutrients, in particular retinoids and carotenoids, might have chemopreventative effects for lung cancer. However, randomized trials failed to validate this hypothesis. In fact, studies found the incidence of lung cancer was increased among smokers with supplementation. Ionizing radiation is also an established lung carcinogen, most convincingly demonstrated from studies showing increased rates of lung cancer among survivors of the atom bombs dropped on Hiroshima and Nagasaki and large excesses among workers exposed to alpha irradiation from radon in underground uranium mining. Prolonged exposure to low-level radon in homes might impart a risk of lung cancer equal or greater than that of ETS. Prior lung diseases such as chronic bronchitis, emphysema, and tuberculosis have been linked to increased risks of lung cancer as"
        },
        {
            "id": "InternalMed_Harrison_6276",
            "title": "InternalMed_Harrison",
            "content": "to radiation carcinogenesis. A woman who receives mantle field radiation therapy for Hodgkin\u2019s disease at age 25 years has a 30% risk of developing breast cancer by age 55 years. This is comparable in magnitude to genetic breast cancer syndromes. Women treated after age 30 years have little or no increased risk of breast cancer. No data suggest that a threshold dose of therapeutic radiation exists below which the incidence of second cancers is decreased. High rates of second tumors occur in people who receive as little as 1000 cGy."
        },
        {
            "id": "Surgery_Schwartz_3829",
            "title": "Surgery_Schwartz",
            "content": "or ethnic background have a multifactorial cause, and improvements in outcome will require correction of many public health problems at both the patient and provider levels.Advances in the ability to characterize breast cancer sub-types and the genetics of the disease are now provoking specula-tion regarding possible hereditary influences on breast cancer risk that are related to racial or ethnic ancestry.121 These questions become particularly compelling when one looks at disparities in breast cancer burden between African Americans and Cau-casians. Lifetime risk of breast cancer is lower for African Americans, yet a paradoxically increased breast cancer mortal-ity risk also is seen. African Americans also have a younger age distribution for breast cancer; among women <45 years of age, breast cancer incidence is highest among African Americans compared to other subsets of the American population. Lastly and most provocatively, African American women of all ages have notably higher"
        },
        {
            "id": "InternalMed_Harrison_7942",
            "title": "InternalMed_Harrison",
            "content": "Second malignancies in patients cured of cancer are a major cause of death, and treated cancer patients must be monitored for their occurrence. The induction of second malignancies is governed by the complex interplay of a number of factors including age, gender, environmental exposures, genetic susceptibility, and cancer treatment itself. In a number of settings, the events leading to the primary cancer themselves increase the risk of second malignancies. Patients with lung cancer are at increased risk of esophageal and head and neck cancers, and vice versa, due to shared risk factors including alcohol and tobacco abuse. Indeed, the risk of developing a second primary head and neck, esophageal, or lung cancer is also increased in these patients. Patients with breast cancer are at increased risk of breast cancer in the opposite breast. Patients with Hodgkin\u2019s lymphoma are at risk for nonHodgkin\u2019s lymphomas. Genetic cancer syndromes (e.g., multiple endocrine neoplasia or Li-Fraumeni,"
        },
        {
            "id": "InternalMed_Harrison_7945",
            "title": "InternalMed_Harrison",
            "content": "Patients receiving radiation have an increasing and lifelong risk of second malignancies that is 1\u20132% in the second decade following treatment but increases to >25% after 25 years. These malignancies include cancers of the thyroid and breast, sarcomas, and CNS cancers, which often tend to be aggressive and have a poor prognosis. An example of organ-, age-, and sex-dependent radiation-induced secondary malignancy is breast cancer, in which the risk is small with radiation in women under age 30 but increases about 20-fold over baseline in women over 30. A 25-year-old woman treated with mantle radiation for Hodgkin\u2019s lymphoma has a 29% actuarial risk of developing breast cancer by age 55."
        },
        {
            "id": "Gynecology_Novak_3322",
            "title": "Gynecology_Novak",
            "content": "The patient should be questioned about the following risk factors for breast cancer (see Chapter 40 for more details): Increasing age (approximately 50% of breast cancers occur after age 65) Age of menarche less than 12 years Nulliparity or first pregnancy at greater than 30 years of age Late menopause (older than 55 years of age) Family history of breast cancer (especially premenopausal or bilateral disease) Number of first-degree relatives with breast cancer and their ages when diagnosed Family history of male breast cancer Inherited conditions associated with a high risk for breast cancer, including BRCA1 and BRCA2 genes, Li-Fraumeni syndrome, Cowden\u2019s disease, ataxia telangiectasia syndrome, and Peutz-Jeghers syndrome Other malignancies (ovary, colon, and prostate) Pathology of previous breast biopsy showing atypia or lobular or ductal carcinoma Hormone therapy Alcohol consumption Postmenopausal weight gain Personal history of breast cancer"
        },
        {
            "id": "Surgery_Schwartz_2196",
            "title": "Surgery_Schwartz",
            "content": "diagnosis may be preferable in a patient at high risk for breast cancer.98Cancer risk assessment starts with taking a complete his-tory that includes history of environmental exposures to potential carcinogens and a detailed family history. Risk assessment for breast cancer, for example, includes obtaining a family history to determine whether another member of the family is known to carry a breast cancer susceptibility gene; whether there is famil-ial clustering of breast cancer, ovarian cancer, thyroid cancer, sarcoma, adrenocortical carcinoma, endometrial cancer, brain tumors, dermatologic manifestations, leukemia, or lymphoma; and whether the patient is from a population at increased risk, such as individuals of Ashkenazi Jewish descent. Patients who have a family history suggestive of a cancer susceptibility syn-drome such as hereditary breast-ovarian syndrome, Li-Fraumeni Syndrome, or Cowden\u2019s Disease would benefit from genetic counseling and possibly genetic testing.There are"
        },
        {
            "id": "Surgery_Schwartz_2339",
            "title": "Surgery_Schwartz",
            "content": "are summarized in Table 10-13.171,176 In addition to these effects, a small increase in the risk for secondary malignancies is attribut-able to radiation therapy.CANCER PREVENTIONThe truth of the old axiom \u201cAn ounce of prevention is worth a pound of cure\u201d is being increasingly recognized in oncology. Cancer prevention can be divided into three categories: (a) pri-mary prevention (i.e., prevention of initial cancers in healthy indi-viduals), (b) secondary prevention (i.e., prevention of cancer in individuals with premalignant conditions), and (c) tertiary pre-vention (i.e., prevention of second primary cancers in patients cured of their initial disease).The systemic or local administration of therapeutic agents to prevent the development of cancer, called chemoprevention, is being actively explored for several cancer types. In breast can-cer, the NSABP Breast Cancer Prevention Trial demonstrated that tamoxifen administration reduces the risk of breast cancer by one half and reduces the"
        },
        {
            "id": "Surgery_Schwartz_2067",
            "title": "Surgery_Schwartz",
            "content": "cancer death in both sexes worldwide.Overall, the incidence of breast cancer is rising in most countries. Incidence varies from 19.3 per 100,000 women in Eastern Africa to 89.7 per 100,000 women in Western Europe, and are high in developed regions of the world (except Japan) and low in most of the developing regions.4 Although breast cancer has been linked to cancer susceptibility genes, mutations in these genes account for only 5% to 10% of breast tumors, which suggests that the wide geographic variations in breast cancer incidence are not due to geographic variations in the prevalence of these genes. Most of the differences, therefore, are attributed to differences in reproductive factors, diet, alcohol, obesity, physical activity, and other environmental differences. Indeed, breast cancer risk increases significantly in females MalesFemalesBreastLung & bronchusColon & rectumUterine corpusNon-Hodgkin lymphomaThyroidMelanoma of the skinPancreasLeukemiaKidney & renal pelvisAll"
        },
        {
            "id": "Pathology_Robbins_1972",
            "title": "Pathology_Robbins",
            "content": "Table 8.8 Effects of Whole-Body Ionizing Radiation tumors, and on older studies showing that radiation therapy to the chest is particularly likely to produce breast cancers when administered to adolescent females. \u2022 Occupational exposure and cancer development. Radon is a ubiquitous product of the spontaneous decay of uranium. The carcinogenic agents are two radon decay byproducts (polonium-214 and polonium-218, or \u201cradon daughters\u201d), which emit alpha particles and have a short half-life. These particulates are deposited in the lung, and chronic exposure in uranium miners may give rise to lung carcinomas. Risks also are present in those homes in which the levels of radon are very high, comparable to those found in mines. However, there is little or no evidence to suggest that radon contributes to the risk of lung cancer in the average household."
        },
        {
            "id": "Gynecology_Novak_3440",
            "title": "Gynecology_Novak",
            "content": "1. Pearlman, MD, Giffin JL. Benign breast disease. Obstet Gynecol 2010;116:747\u2013747. 2. Harris J, Morrow M, Lippman M, et al. Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins, 2009. 3. Miltenburg DM, Speights VO Jr. Benign breast disease. Obstet Gynecol Clin North Am 2008;35:285\u2013300. 4. Gail Risk Assessment. Breast cancer risk assessment tool. Available online at: http://www.cancer.gov/bcrisktool 5. O\u2019Brien MM, Donaldson SS, Balise RR, et al. Second malignant neoplasms in survivors pediatric Hodgkin\u2019s lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 2010;28:1232\u2013 1239. 6. Rodden AM. Common breast concerns. Prim Care 2009;36:103\u2013 113. 7. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin. 2008;58:161\u2013179. 8."
        },
        {
            "id": "Pathology_Robbins_4405",
            "title": "Pathology_Robbins",
            "content": "Race/Ethnicity. The highest rate of breast cancer is in women of European descent, largely because of a higher incidence of ER-positive cancers. Hispanic and African American women tend to develop cancer at a younger age and are more likely to develop aggressive tumors. Such disparities are thought to result from a combination of differences in genetics, social factors, and access to health care and are an area of intense study. Reproductive History. Early age of menarche, nulliparity, absence of breastfeeding, and older age at first pregnancy are all associated with increased risk, probably because each increases the exposure of \u201cat-risk\u201d breast epithelial cells to estrogenic stimulation."
        },
        {
            "id": "Gynecology_Novak_6514",
            "title": "Gynecology_Novak",
            "content": "Breast Cancer Breast cancer is a major health concern for menopausal women, as it is the most common cancer in women and the second leading cause of cancer death (56). The lifetime risk of invasive breast cancer for US women is 12%; therefore, any therapies that increase or reduce this risk will have a major impact on women\u2019s health. Risk factors for breast cancer include age, family history, early menarche, late menopause, and prior breast disease, including epithelial atypia and cancer. Risk is reduced in women who had bilateral oophorectomy or a term pregnancy before the age of 30. Many of these risk factors are consistent with the hypothesis that prolonged estrogen exposure increases breast cancer risk."
        },
        {
            "id": "InternalMed_Harrison_7892",
            "title": "InternalMed_Harrison",
            "content": "Subsequent pregnancies following gestational breast cancer do not appear to influence relapse rate or overall survival. A meta-analysis found that pregnancy in breast cancer survivors was associated with a reduced the risk of dying from breast cancer by as much as 42%. This finding, however, is heavily confounded by the \u201chealthy survivor effect\u201d; women with more extensive or advanced disease are more likely to avoid pregnancy."
        },
        {
            "id": "Gynecology_Novak_7812",
            "title": "Gynecology_Novak",
            "content": "Diet, Obesity, and Alcohol There are marked geographic differences in the incidence of breast cancer that may be related to diet. A meta-analysis demonstrated an association between a healthy diet and lower risk of breast cancer (8). Although a definitive relationship between total alcohol consumption and increased risk of breast cancer has yet to be determined, high wine intake was associated with elevated risk (8,9). The risk of breast cancer increases with the length of a woman\u2019s reproductive phase (10). Although early menarche was reported among breast cancer patients, early menopause appears to protect against the development of the disease, with artificial menopause from oophorectomy lowering the risk more than early natural menopause (11). There is no clear association between the risk of breast cancer and menstrual irregularity or the duration of menses."
        },
        {
            "id": "Surgery_Schwartz_3823",
            "title": "Surgery_Schwartz",
            "content": "and Ashkenazi Jewish women have an above-average incidence.The incidence rates of breast cancer increased in most countries through the 1990s. Since the estimates for 1990, there was an overall increase in incidence rates of approximately 0.5% annually. It was predicted that there would be approxi-mately 1.4 million new cases in 2010. The cancer registries in China have noted annual increases in incidence of up to 3% to 4%, and in eastern Asia, increases are similar.Data from the SEER program reveal declines in breast cancer incidence over the past decade, and this is widely attrib-uted to decreased use of hormone replacement therapy as a con-sequence of the Women\u2019s Health Initiative reports.118Breast cancer burden has well-defined variations by geog-raphy, regional lifestyle, and racial or ethnic background.119 In general, both breast cancer incidence and mortality are rela-tively lower among the female populations of Asia and Africa, relatively underdeveloped nations, and nations"
        },
        {
            "id": "InternalMed_Harrison_31956",
            "title": "InternalMed_Harrison",
            "content": "Long-term exposure to environmental tobacco smoke increases the risk of lung cancer and coronary artery disease among nonsmokers. It also increases the incidence of respiratory infections, chronic otitis media, and asthma in children and causes exacerbation of asthma in children. Some evidence suggests that environmental tobacco smoke exposure may increase the risk of premenopausal breast cancer. Patients who continue to smoke during treatment for cancer with chemotherapy or radiation have poorer outcomes and reduced survival."
        },
        {
            "id": "Surgery_Schwartz_2179",
            "title": "Surgery_Schwartz",
            "content": "If PAH is coated on asbestos, PAH uptake is increased.90 Both PAH and asbestos impair lung clearance, potentially increasing uptake further. Therefore, physical car-cinogens may be synergistic with chemical carcinogens.Radiation is the best-known agent of physical carcinogens and is classified as ionizing radiation (X-rays, gamma rays, and alpha and beta particles) or nonionizing radiation (UV). The car-cinogenic potential of ionizing radiation was recognized soon after Wilhelm Conrad Roentgen\u2019s discovery of X-rays in 1895. Within the next 20 years, a large number of radiation-related skin cancers were reported. Long-term follow-up of survivors of the atomic bombing of Hiroshima and Nagasaki revealed that virtually all tissues exposed to radiation are at risk for cancer.Radiation can induce a spectrum of DNA lesions that includes damage to the nucleotide bases and cross-linking, and DNA singleand double-strand breaks (DSBs). Misrepaired DSBs are the principal lesions of importance in"
        },
        {
            "id": "InternalMed_Harrison_309",
            "title": "InternalMed_Harrison",
            "content": "is very difficult given the need for long-term follow-up of an unscreened population to determine the true incidence of disease over time. Recent estimates suggest that as much as 15\u201325% of breast cancers identified by mammography screening and 15\u201337% of prostate cancers identified by prostate-specific antigen testing may never have presented clinically. Screening tests also have the potential to create unwarranted anxiety, particularly in conjunction with false-positive findings. Although multiple studies have documented increased anxiety through the screening process, there are few data suggesting this anxiety has long-term adverse consequences, including subsequent screening behavior. Screening tests that involve radiation (e.g., mammography, chest CT) add to the cumulative radiation exposure for the screened individual. The absolute amount of radiation is very small from any of these tests, but the overall impact of repeated exposure from multiple sources is still being"
        },
        {
            "id": "Surgery_Schwartz_3780",
            "title": "Surgery_Schwartz",
            "content": "and reanalyzed data from a number of studies totaling 52,705 women with breast cancer and 108,411 women without breast cancer. They found an increased risk of breast cancer with every use of estrogen replacement therapy. They also reported increased risk among current users but not past users and risk increased with increasing duration of use of hormone replacement therapy.69 Cheblowski et al also reported from the WHI study that estrogen + progesterone increased the incidence of breast cancer.70 This was con-firmed by the Million Women study, which also showed that the increased risk was substantially greater for the combined estrogen + progesterone replacement therapy than other types of hormone replacement therapy.71Breast Cancer Screening. Routine use of screening mam-mography in women \u226550 years of age has been reported to reduce mortality from breast cancer by 25%.72 This reduc-tion comes at an acceptable economic cost. More recently, there has been debate over the potential"
        },
        {
            "id": "Surgery_Schwartz_4104",
            "title": "Surgery_Schwartz",
            "content": "GH. The management of women at high risk for the development of breast cancer: risk estimation and preven-tative strategies. Cancer Treat Rev. 2003;29:79-89. 66. Schrag D, Kuntz KM, Garber JE, et al. Decision analysis\u2014effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997;336:1465-1471. 67. Vogel VG. Management of the high-risk patient. Surg Clin North Am. 2003;83:733-751. 68. Wu K, Brown P. Is low-dose tamoxifen useful for the treat-ment and prevention of breast cancer? J Natl Cancer Inst. 2003;95:766-767. 69. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collabora-tive reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women with-out breast cancer. Lancet. 1997;350:1047-1059. 70. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in"
        },
        {
            "id": "InternalMed_Harrison_17238",
            "title": "InternalMed_Harrison",
            "content": "It is desirable to continue follow-up over the long termin some circumstances. In general, only persons who are exposed to <8\u201310 Gy of whole-body irradiation have a chance to survive in the long term, and they are at risk of developing cataracts, sterility, and cancers as well as lung, kidney, and bone marrow problems. In light of their age, their gender, and the amount and type of exposure, they should be followed for many years. A major public health issue is the risk of secondary malignancy in individuals and populations that have been exposed to low doses of radiation. Leukemia and breast, brain, thyroid, and lung cancer develop most commonly, but the exposed population is at increased risk for many other cancers as well. Appropriate follow-up protocols should be based on the type of exposure and the exposed population. In cases of internal contamination, long-term follow-up should be focused on the organ at risk. Substantial psychosocial support will likely be needed for a"
        },
        {
            "id": "Surgery_Schwartz_3775",
            "title": "Surgery_Schwartz",
            "content": "relatives with breast cancer and their age at diagnosis. Risk factors that are less consistently associated with breast cancer (diet, use of oral contraceptives, lactation) or are rare in the general population (radiation exposure) are not included in either the Gail or Claus risk assessment model. Other models have been proposed that account for mammographic breast density in assessing breast cancer risk.54,56Neither the Gail model nor the Claus model accounts for the risk associated with mutations in the breast cancer suscepti-bility genes BRCA1 and BRCA2 (described in detail in the fol-lowing section). The BRCAPRO model is a Mendelian model that calculates the probability that an individual is a carrier of a mutation in one of the breast cancer susceptibility genes based on their family history of breast and ovarian cancer.57 The prob-ability that an individual will develop breast or ovarian cancer is derived from this mutation probability based on age-specific incidence curves for"
        }
    ],
    "scores": [
        0.03669879220337936,
        0.034287100677734605,
        0.032504347812862676,
        0.029605901766647257,
        0.029508833236264805,
        0.029400858827403314,
        0.025081648252379962,
        0.02474972191323693,
        0.024175991041008267,
        0.023280083264193435,
        0.023251042139139075,
        0.023234916051274444,
        0.021816792996063226,
        0.02163903781154455,
        0.021510450197216303,
        0.02139292045878046,
        0.020876814882032666,
        0.01946875588179936,
        0.018608274190756446,
        0.018605053651782624,
        0.017980970811159493,
        0.01703639263447876,
        0.016516816516816517,
        0.016298946531504672,
        0.016280566280566282,
        0.01575682382133995,
        0.015727149377081535,
        0.015455304928989139,
        0.015396368337544809,
        0.015390965915791957,
        0.015304156344618774,
        0.015173285821024196
    ]
}